Supplementary methods: in vitro studies

Cell isolation and culture
Human umbilical vein-derived endothelial cells (EC) were obtained by ATCC (PCS-100-010-ATCC, Manassas VA). EC were plated with EBM medium supplemented with 10% fetal calf serum (FCS -GE Health Care, Boston MA) and different endothelial growth factors (Lonza, Basel, Switzerland) . Human Vascular Smooth Muscular Cells (VSMC) were obtained by ATCC and grown in Dulbecco Modified Eagle Medium (DMEM -GE Health Care) with 10% of FCS.
Experiments were performed without FCS and after 24h (EC except angiogenesis), 72h (angiogenesis assay) or 96h (VSMC) incubation with patients' plasma diluted 1:10. Peripheral Blood Mononuclear Cells (PBMC) were obtained from healthy volunteer after isolation with FicollHypaque (GE Health Care) density gradient and added to cell cultures in selected experiments.
Functional assays
Cell death: EC were cultured in 96-well plates, incubated with appropriate stimuli, subjected to TUNEL assay (Chemicon Int. Temecula, CA) and analyzed under a fluorescence microscope to detect stained cells in 10 non-consecutive fields. Cell calcification: intracellular calcium deposits were quantified by red-alizarin staining. VSMC were cultured in 24-well plates and fixed with 4% paraformaldehyde in PBS for 45 min at 4°C.
Cells were then washed in distilled water, exposed to Alizarin Red (2% aqueous, Sigma Aldrich, St Louis, MO) for 5 min, washed again and analyzed by inverted light microscopy. Cell lysates were analyzed in an automatized spectrophotometer at a wavelength of 570 nm.
Quantitative RT-PCR for RUNX2: total RNA was extracted by VSMC after appropriate stimulation using mirVana RNA isolation kit (Life Technologies). RNA concentration and purity were detected by the NanoDrop1000 spectrophotometer. We evaluated RUNX2 mRNA expression by using High 
